MOLINELLI, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 5.582
EU - Europa 2.388
AS - Asia 2.049
SA - Sud America 515
AF - Africa 187
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 10.729
Nazione #
US - Stati Uniti d'America 5.498
SG - Singapore 823
CN - Cina 572
IT - Italia 565
BR - Brasile 446
RU - Federazione Russa 344
HK - Hong Kong 270
IE - Irlanda 260
SE - Svezia 243
DE - Germania 216
UA - Ucraina 166
FR - Francia 150
VN - Vietnam 142
GB - Regno Unito 138
CI - Costa d'Avorio 98
FI - Finlandia 73
IN - India 62
CA - Canada 49
NL - Olanda 48
DK - Danimarca 46
TR - Turchia 43
MA - Marocco 37
ZA - Sudafrica 34
AT - Austria 31
JP - Giappone 31
AR - Argentina 30
MX - Messico 29
PL - Polonia 28
ES - Italia 23
KR - Corea 23
BD - Bangladesh 21
BE - Belgio 18
IQ - Iraq 14
EC - Ecuador 12
ID - Indonesia 11
GR - Grecia 8
LT - Lituania 8
UZ - Uzbekistan 7
CL - Cile 6
CZ - Repubblica Ceca 6
PE - Perù 6
CO - Colombia 5
EG - Egitto 5
TH - Thailandia 5
DZ - Algeria 4
KE - Kenya 4
PY - Paraguay 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CH - Svizzera 3
EU - Europa 3
HU - Ungheria 3
IL - Israele 3
PT - Portogallo 3
TW - Taiwan 3
AZ - Azerbaigian 2
BG - Bulgaria 2
GE - Georgia 2
JM - Giamaica 2
KG - Kirghizistan 2
PH - Filippine 2
PK - Pakistan 2
SA - Arabia Saudita 2
SM - San Marino 2
SN - Senegal 2
TN - Tunisia 2
UY - Uruguay 2
BB - Barbados 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
LI - Liechtenstein 1
MT - Malta 1
MY - Malesia 1
NI - Nicaragua 1
NR - Nauru 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
RS - Serbia 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.729
Città #
Ashburn 789
Chandler 620
Singapore 530
Dallas 488
Des Moines 313
Hong Kong 269
Boardman 261
Dublin 251
Fairfield 232
New York 195
Jacksonville 189
Beijing 129
Los Angeles 129
Seattle 118
The Dalles 118
Wilmington 108
Abidjan 97
Houston 96
Munich 91
Woodbridge 91
Lawrence 82
Princeton 82
Moscow 76
Cambridge 72
Ann Arbor 62
San Mateo 62
Council Bluffs 59
Ancona 57
Centro 57
Hefei 54
Ho Chi Minh City 46
Chicago 45
London 45
São Paulo 41
Buffalo 40
San Diego 40
Turin 40
Turku 38
Washington 38
Pune 32
Shanghai 31
Guangzhou 29
Johannesburg 29
Boydton 28
Rome 27
Santa Clara 27
Brooklyn 26
Hanoi 25
Wuhan 25
Tokyo 24
Warsaw 24
Columbus 23
Montreal 21
Nuremberg 21
Denver 20
Orem 20
Brussels 18
Milan 18
San Francisco 17
Urbisaglia 16
Helsinki 15
Stockholm 15
Tolentino 15
Vienna 15
Marche 14
San Jose 14
Atlanta 13
Amsterdam 12
Chennai 12
Poplar 12
Curitiba 11
Haiphong 11
Salt Lake City 11
Boston 10
Da Nang 10
Kazan' 10
Manchester 10
Phoenix 10
Civitanova Marche 9
Elk Grove Village 9
Menlo Park 9
Porto Alegre 9
Toronto 9
Ascoli Piceno 8
Brasília 8
Chaozhou 8
Dronten 8
Jiaxing 8
Kilburn 8
Norwalk 8
Rio de Janeiro 8
Ankara 7
Belo Horizonte 7
Falls Church 7
Frankfurt am Main 7
Mexico City 7
Perugia 7
Tashkent 7
Wuxi 7
Buenos Aires 6
Totale 7.042
Nome #
Paraoxonase-2: A potential biomarker for skin cancer aggressiveness 275
Melanoma e tessuto adiposo peritumorale: studio preliminare sul ruolo delle adipocitochine nella caratterizzazione e prognosi di malattia 164
A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor. 154
Involvement of the oral cavity in psoriasis: results of a clinical study 141
Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study 140
Characterization and clonal diffusion of ceftaroline non-susceptible mrsa in two hospitals in central Italy 137
Differential expression of nicotinamide n-methyltransferase in cutaneous keratoacanthoma and squamous cell carcinoma: an immunohistochemical study 129
Diagnostic and prognostic role of nicotinamide N-methyltransferase in cutaneous malignant melanoma 127
The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review 124
The effect of low-carbohydrates calorie-restricted diet on visceral adipose tissue and metabolic status in psoriasis patients receiving TNF-alpha inhibitors: results of an open label controlled, prospective, clinical study 122
Clinical outcomes and feasibility of the multidisciplinary management of patients with psoriatic arthritis: two-year clinical experience of a dermo-rheumatologic clinic 122
Nicotinamide N-methyltransferase in nonmelanoma skin cancers 122
Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin 120
Oxidative stress and alterations of paraoxonases in atopic dermatitis 120
Bimekizumab: dual inhibition as a promising tool in the management of hidradenitis suppurativa 119
Biologic Therapy in Psoriasis: Safety Profile 119
Biologic Therapy in Inflammatory and Immunomediated Skin Diseases: Safety Profile 118
Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment 116
MiR-146a-5p correlates with clinical efficacy in psoriasis patients treated with the TNF alpha inhibitor Adalimumab 115
Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report 115
Familial lupus panniculitis: two cases, same diagnosis, what evolution? 113
Differential immunohistochemical expression of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 113
Global coronavirus pandemic (SARS-CoV-2): Past, present, and future of pediatric dermatology 112
Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone 111
Review: A safety profile of dalbavancin for onand off-label utilization 111
Ingenol mebutate in actinic keratosis: A clinical, videodermoscopic and immunohistochemical study 108
Alexandrite laser as an adjuvant therapy in the management of mild to moderate hidradenitis suppurativa: A controlled prospective clinical study 108
Beyond Nicotinamide Metabolism: Potential Role of Nicotinamide N‐Methyltransferase as a Biomarker in Skin Cancers 106
Hidradenitis suppurativa in a prepubertal case series: a call for specific guidelines 103
Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature 103
Biologic Therapy in Psoriasis (Part II): Efficacy and Safety of New Treatment Targeting IL23/IL-17 Pathways 102
Acne agminata in Crohn's disease: A diagnostic and therapeutic challenge case for dermatologists 102
Reticulated acanthoma with sebaceous differentiation 101
Primary Dermal Melanoma: A Rare Clinicopathological Variant Mimicking Metastatic Melanoma 101
Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma 100
Biologic Therapy in Psoriasis (Part I): Efficacy and Safety of Tumor Necrosis Factor- alpha Inhibitors 100
Management of patients with hidradenitis suppurativa during the COVID-19 pandemic: Risk and benefit of immunomodulatory therapy 100
Nicotinamide N-methyltransferase gene silencing enhances chemosensitivity of melanoma cell lines 99
Effects of in vivo application of an overnight patch containing Allium cepa, allantoin, and pentaglycan on hypertrophic scars and keloids: Clinical, videocapillaroscopic, and ultrasonographic study 99
Coexistence of systemic lupus erythematosus, Hashimoto's thyroiditis, and bilateral breast cancer in the same patient: a random association? 98
Biologic Therapy in Immune Mediated Inflammatory Disease: Basic Science and Clinical Concepts 98
IL-17, IL-23, and p73 expression in cutaneous melanoma: a pilot study 96
How can I take care of you? The dermatologist meets patients' needs during the COVID-19 pandemic 96
Paraoxonase-2: a novel molecular target to enhance chemosensitivity in melanoma and triple negative breast cancer cells 95
Tetraspanin CD9 Expression Predicts Sentinel Node Status in Patients with Cutaneous Melanoma 95
Topical application of fumaric acid esters improves appearance of nail psoriasis 94
Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience 93
Ixekizumab for treatment of moderate to severe plaque psoriasis: real world clinical experience. 93
Metabolic Comorbidities and Cardiovascular Disease in Pediatric Psoriasis: A Narrative Review 92
Mycosis Fungoides-like Eruption and Infliximab 91
Kaposi-Juliusberg varicelliform eruption in patient suffering from Darier-White disease: a case report and review of the literature 91
Methicillin-resistant Staphylococcus aureus as a cause of chronic wound infections: Alternative strategies for management 90
Acitretin plus macrolides and acitretin monotherapy in the management of hidradenitis suppurativa 90
Efficacy of oral zinc and nicotinamide as maintenance therapy for mild/moderate hidradenitis suppurativa: A controlled retrospective clinical study 90
Humoral and cellular immunity after mRNA COVID-19 vaccine in psoriatic patients on biological or immunosuppressive therapy: a real-life experience 88
Nicotinamide N-methyltransferase: a new potential biomarker for cutaneous malignant melanoma 88
Relapsing acute generalized exanthematous pustolosis: a guess. 88
Immunohistochemical expression of nicotinamide N-methyltransferase in cutaneous basal and squamous cell carcinomas 88
Time to restart: protocol of resumption of activities of a dermatological clinic of a level II hospital in the COVID-19 era 88
Immunohistochemical analysis of paraoxonase-2 in actinic keratosis and squamous cell carcinoma 88
The Double-Edged Sword of Oxidative Stress in Skin Damage and Melanoma: From Physiopathology to Therapeutical Approaches 87
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study 87
Comparison of clinical and ultrasound scores in patients with hidradenitis suppurativa: results from an Italian ultrasound working group 86
Renbök phenomenon in a Down syndrome patient with hidradenitis suppurativa and alopecia areata 86
Prevention of conjunctivitis in patients with atopic dermatitis undergoing treatment with dupilumab: an Italian single-centre experience 84
Metabolic Comorbidities in Pediatric Atopic Dermatitis: A Narrative Review 83
Periodontal Disease: An Oral Manifestation of Psoriasis or an Occasional Finding? 82
Efficacy of cathelicidin ll-37 in an mrsa wound infection mouse model 82
Baricitinib: The first jak inhibitor approved in europe for the treatment of moderate to severe atopic dermatitis in adult patients 82
Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of Hallopeau 82
Prognosis in early stage cutaneous T-cell lymphoma treated with psoralen plus ultraviolet A irradiation and low-dose interferon-α: Long-term efficacy and survival according to conventional and emerging clinical endpoints 80
Treatment of Moderate-to-Severe Psoriasis in the Presence of Kaposi's Varicelliform Eruption 80
Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate-to-severe hidradenitis suppurativa 78
Melanoma and subcutaneous adipose tissue: Role of peritumoral adipokines in disease characterization and prognosis 77
Efficacy and safety of topical resorcinol 15% as long-term treatment of mild-to-moderate hidradenitis suppurativa: a valid alternative to clindamycin in the panorama of antibiotic resistance 77
Knockdown of nicotinamide N-methyltransferase suppresses proliferation, migration and chemoresistance of Merkel cell carcinoma cells in vitro 76
Fractionated CO2 Laser in Combination with Topical Tacrolimus for Chronic Alopecia Areata: A Case Series Study 75
Pyoderma gangrenosum succesfully treated with golimumab: Case report and review of the literature 75
Atypical Scleroderma-like Chronic GVHD in a Liver Transplant Patient, Clinical and MRI Correlations 74
Salivary interleukin-1β: Oral inflammatory biomarker in patients with psoriasis. 74
Skin involvement in patients with psoriatic arthritis: preliminary results of treatment with apremilast in real world setting. 74
Phototherapy in Dermatology 73
Vaccines for COVID-19 in patients with atopic dermatitis: Three things every dermatologist should know 73
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art 72
Safety and efficacy of vaccines during covid-19 pandemic in patients treated with biological drugs in a dermatological setting 72
Oral oxybutynin chloride therapy in the management of hidradenitis suppurativa: A prospective study 71
The role of the optical super high magnification dermoscopy (O.S.H.M.D) in the management of melanocytic lesions 71
Sneddon-Wilkinson disease and monoclonal gammopathy of undetermined significance in the elderly: Case report 71
The Role of Diet in Children with Psoriasis: Emerging Evidence and Current Issues 70
Immunohistochemical expression of nicotinamide N-methyltransferase in lymph node metastases from cutaneous malignant melanoma 70
Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background 70
The Effect of Dalbavancin in Moderate to Severe Hidradenitis Suppurativa 69
Circulating tumor DNA-based assessment of molecular residual disease in non-metastatic melanoma 69
Expression of Paraoxonase-2 in Different Stages of Cutaneous T Cell Lymphoma: Is It a Potential Biomarker for Aggressiveness? 69
Biological treatments for pediatric psoriasis: state of the art and future perspectives 68
Pharmacodynamics of TNF α inhibitors for the treatment of psoriasis 68
Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study 68
Sex-related differences of clinical features in hidradenitis suppurativa: analysis of an Italian-based cohort. 67
Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination management 67
Tissue Biomarkers Predicting Lymph Node Status in Cutaneous Melanoma 65
Totale 9.625
Categoria #
all - tutte 62.024
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.024


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021616 0 0 0 0 0 84 112 47 67 92 155 59
2021/2022692 16 100 27 12 29 46 25 53 47 28 137 172
2022/20231.897 132 187 122 176 114 474 8 103 381 10 130 60
2023/20241.281 160 24 150 135 165 293 27 71 19 85 16 136
2024/20252.399 315 179 75 37 99 98 234 94 499 168 316 285
2025/20263.293 561 409 548 694 739 342 0 0 0 0 0 0
Totale 11.084